ENDPOINTS

Regeneron plans to buy 23andMe for $256M

23andMe has found a buyer. Regeneron will buy the struggling 23andMe through its court-supervised sale for $256 million, the companies disclosed Monday morning. The move comes after a roller coaster for 23andMe in the past ...

May 19, 2025 - 12:34
 0
Regeneron plans to buy 23andMe for $256M
23andMe has found a buyer. Regeneron will buy the struggling 23andMe through its court-supervised sale for $256 million, the companies disclosed Monday morning. The move comes after a roller coaster for 23andMe in the past ...
Read More

Tags:

Previous Article

Meta CTO Addresses Quest 3 Battery Setting Issue Following Bungled Horizon OS Up...

Next Article

CellCentric raises $120M to treat multiple myeloma with capsule

Related Posts

Merck KGaA Q1 earnings: Tariff surcharge for US customers will continue

Merck KGaA Q1 earnings: Tariff surcharge for US custome...

May 15, 2025  0

Trump's drug price plan is light on details, may have little impact

Trump's drug price plan is light on details, may have l...

May 12, 2025  0

Republican tax cut bill includes PBM, drug price negotiation changes

Republican tax cut bill includes PBM, drug price negoti...

May 12, 2025  0